BioSig Announces Successful First-In-Human Use of PURE EP System

February 20, 2019

BioSig Technologies Inc. Issues 2019 Shareholder Letter

February 12, 2019

BioSig Appoints John Kowalski to Lead Commercialization of PURE EP

February 5, 2019

Johnson & Johnson's Biosense Webster’s MaryAnn Edzards Joins BioSig

December 19, 2018

BioSig Technologies To Commence First–in-Human Studies at Mayo Clinic

December 6, 2018

Medical Leaders Join BioSig Clinical Advisory Board

November 28, 2018

BioSig Technologies Signs Agreement with Texas Cardiac Arrhythmia Institute for First–in-Human Studies

November 27, 2018

BioSig Technologies Reinvests in Lafayette College’s InternShift Progam

November 20, 2018

BioSig Technologies Announces New Research Program with Mayo Clinic

November 13, 2018

BioSig Technologies to Ring NASDAQ Opening Bell on November 13, 2018

November 12, 2018